RBC Capital Markets

Athene Prices $1,000,000,000 Investment Grade Senior Notes Offering

Retrieved on: 
Tuesday, March 19, 2024

WEST DES MOINES, Iowa, March 19, 2024 (GLOBE NEWSWIRE) -- Athene Holding Ltd. (“Athene”) today announced it has agreed to sell $1,000,000,000 aggregate principal amount of 6.25% senior notes due 2054.

Key Points: 
  • WEST DES MOINES, Iowa, March 19, 2024 (GLOBE NEWSWIRE) -- Athene Holding Ltd. (“Athene”) today announced it has agreed to sell $1,000,000,000 aggregate principal amount of 6.25% senior notes due 2054.
  • The offering is expected to close on March 22, 2024, subject to satisfaction of customary closing conditions.
  • Athene intends to use the net proceeds from the offering for general corporate purposes, including capital contributions to its insurance subsidiaries to support organic growth.
  • Deutsche Bank Securities, Goldman Sachs & Co. LLC, Morgan Stanley and RBC Capital Markets are acting as joint book-running managers for the offering.

BiomX Announces Closing of the Acquisition of Adaptive Phage Therapeutics and Concurrent $50 Million Financing

Retrieved on: 
Monday, March 18, 2024

CAMBRIDGE, Mass. and NESS ZIONA, Israel, March 18, 2024 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (together with its subsidiaries and/or associates, “BiomX”), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced the closing of its previously announced (March 6, 2024) acquisition (the “Acquisition”) of Adaptive Phage Therapeutics, Inc. (“APT”), a U.S.-based privately-held, clinical-stage biotechnology company pioneering the development of phage-based therapies to combat bacterial infections, and its previously announced $50 million private placement to certain institutional accredited investors, which was led by affiliates of Deerfield Management Company and the AMR Action Fund, and additional investors including the Cystic Fibrosis Foundation, OrbiMed and Nantahala Capital.

Key Points: 
  • “We are very pleased to announce the closing of the APT acquisition, which creates a leading phage company and an advanced pipeline that includes two Phase 2 assets each aimed at treating serious infections with unmet medical need,” said Jonathan Solomon, Chief Executive Officer of BiomX.
  • “We also appreciate the continued support of leading institutional healthcare investors.
  • Haynes and Boone, LLP served as legal counsel to BiomX.
  • Wilmer Cutler Pickering Hale and Dorr LLP served as legal counsel to the placement agents.

Dundee Precious Metals Announces Renewal of Normal Course Issuer Bid

Retrieved on: 
Thursday, March 14, 2024

TORONTO, March 14, 2024 (GLOBE NEWSWIRE) -- Dundee Precious Metals Inc. (TSX: DPM) (the “Company”) announced today that the Toronto Stock Exchange (“TSX”) accepted its notice of intention to renew its normal course issuer bid (the “New Bid”) to purchase certain of its common shares (“Shares”) through the facilities of the TSX.

Key Points: 
  • TORONTO, March 14, 2024 (GLOBE NEWSWIRE) -- Dundee Precious Metals Inc. (TSX: DPM) (the “Company”) announced today that the Toronto Stock Exchange (“TSX”) accepted its notice of intention to renew its normal course issuer bid (the “New Bid”) to purchase certain of its common shares (“Shares”) through the facilities of the TSX.
  • The Company commenced a normal course issuer bid (the “Previous Bid”) on March 1, 2023, which terminated on February 28, 2024.
  • Under the Previous Bid, the Company sought and obtained approval to purchase up to 16.5 million Shares, being approximately 9.8% of the Company’s public float as of February 16, 2023.
  • The Company has re-appointed RBC Capital Markets to make any purchases under the New Bid on its behalf.

RadNet Announces Closing of Public Offering of Common Stock

Retrieved on: 
Tuesday, March 12, 2024

LOS ANGELES, March 12, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services, announced today the closing of its underwritten public offering of 5,232,500 shares of its common stock at a price to the public of $44.00 per share, which includes the exercise in full by the underwriters of their option to purchase up to 682,500 additional shares of its common stock.

Key Points: 
  • LOS ANGELES, March 12, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services, announced today the closing of its underwritten public offering of 5,232,500 shares of its common stock at a price to the public of $44.00 per share, which includes the exercise in full by the underwriters of their option to purchase up to 682,500 additional shares of its common stock.
  • The gross proceeds to RadNet from the offering, before deducting the underwriting discounts and commissions and other offering expenses, are approximately $230.2 million.
  • RadNet intends to use the net proceeds from the proposed offering for general corporate purposes and future acquisitions.
  • RBC Capital Markets, Sidoti & Company, LLC and CJS Securities are acting as co-managers for the offering.

Orion Undertakes A$593 Million Sale of Capstone CDIs on the ASX

Retrieved on: 
Friday, April 5, 2024

The Secondary Offering is expected to close on or about April 9, 2024 (Pacific Time).

Key Points: 
  • The Secondary Offering is expected to close on or about April 9, 2024 (Pacific Time).
  • The net proceeds of the Secondary Offering will be paid directly to the Selling Shareholders.
  • The Selling Shareholders currently hold an aggregate of 152,936,179 Common Shares1, representing approximately 20.3% of the Company’s issued and outstanding Common Shares.
  • The Prospectus Supplement will be filed on the SEDAR+ website maintained by the Canadian Securities Administrators at www.sedarplus.ca on or before April 8, 2024 and released on the ASX.

TD SYNNEX Announces Pricing of Secondary Public Offering of Common Stock and Concurrent Share Repurchase

Retrieved on: 
Friday, April 5, 2024

TD SYNNEX Corporation (NYSE: SNX) (“TD SYNNEX” or the “Company”) today announced the pricing of the previously announced secondary public offering of 5,309,299 shares of its common stock.

Key Points: 
  • TD SYNNEX Corporation (NYSE: SNX) (“TD SYNNEX” or the “Company”) today announced the pricing of the previously announced secondary public offering of 5,309,299 shares of its common stock.
  • The offering is expected to close on or about April 9, 2024, subject to customary closing conditions.
  • TD SYNNEX will not receive any of the proceeds from the sale of shares by the Selling Stockholders in the offering.
  • In addition, the Company has agreed to purchase from the underwriters 1,750,000 shares of common stock that are the subject of the offering at a price per share equal to the price per share to be paid by the underwriters to the Selling Stockholders (the “Concurrent Share Repurchase”) under the Company’s existing share repurchase program.

TD SYNNEX Announces Launch of Secondary Public Offering of Common Stock and Concurrent Share Repurchase

Retrieved on: 
Thursday, April 4, 2024

TD SYNNEX is not selling any shares of its common stock and will not receive any proceeds from the sale of the shares by the Selling Stockholders in the offering.

Key Points: 
  • TD SYNNEX is not selling any shares of its common stock and will not receive any proceeds from the sale of the shares by the Selling Stockholders in the offering.
  • In addition, the Company has authorized the purchase from the underwriters of 1,750,000 shares of common stock as part of the secondary public offering (the “Concurrent Share Repurchase”).
  • The Concurrent Share Repurchase is part of the Company’s existing share repurchase program.
  • The Company intends to fund the Concurrent Share Repurchase from existing cash on hand.

Silver Lake to Take Endeavor Private

Retrieved on: 
Tuesday, April 2, 2024

Silver Lake believes that when consolidating all of TKO’s value into Endeavor, the combined total enterprise value of $25 billion will make this the largest private equity sponsor public-to-private investment transaction in over a decade, and the largest ever in the media and entertainment sector.

Key Points: 
  • Silver Lake believes that when consolidating all of TKO’s value into Endeavor, the combined total enterprise value of $25 billion will make this the largest private equity sponsor public-to-private investment transaction in over a decade, and the largest ever in the media and entertainment sector.
  • On the unaffected date, the equity value was $8.2 billion, and the premium to be paid by Silver Lake represents $4.6 billion more equity value to all Endeavor stockholders.
  • Ariel Emanuel, CEO of Endeavor, said: "Since 2012, Endeavor’s strategic partnership with Silver Lake and Egon Durban have been central to our evolution into the global sports and entertainment leader we are today.
  • Egon, Stephen, and the broader Silver Lake team have been and will continue to be phenomenal partners in Endeavor’s journey, and we look forward to the road ahead.”
    Stephen Evans, Managing Director of Silver Lake and a Director of Endeavor, said: “The team at Silver Lake is proud of our longstanding partnership with Endeavor, marked by more than $3.5 billion of direct investment across six distinct transactions over 12 years.

Zinnia Closes Acquisition of Ebix’s North American Life and Annuity Assets

Retrieved on: 
Monday, April 1, 2024

Zinnia Corporate Holdings (“Zinnia” or “the Company”), an Eldridge Industries business and leading life and annuity insurance technology services company, and Ebix, Inc. (“Ebix”), a supplier of software solutions, today announced that Zinnia’s acquisition of Ebix’s North American Life and Annuity Assets (the “L&A Assets”) has closed.

Key Points: 
  • Zinnia Corporate Holdings (“Zinnia” or “the Company”), an Eldridge Industries business and leading life and annuity insurance technology services company, and Ebix, Inc. (“Ebix”), a supplier of software solutions, today announced that Zinnia’s acquisition of Ebix’s North American Life and Annuity Assets (the “L&A Assets”) has closed.
  • Zinnia will be welcoming over 770 new team members across 6 locations in India and the United States.
  • Global operations across the L&A Assets will be uninterrupted for customers and partners, providing continuity for the life insurance and annuity ecosystem.
  • The acquisition will further enable Zinnia to better serve carriers, distributors, and consumers as it builds the modern rails of the insurance industry.

Somerset Announced Close of Reinsurance Transaction With Prudential

Retrieved on: 
Monday, April 1, 2024

Somerset Reinsurance Ltd. ("Somerset"), a leading provider of reinsurance solutions to the U.S. life insurance and annuity market, announced today the close of its reinsurance transaction with Prudential Financial, Inc. (NYSE: PRU) (“Prudential”).

Key Points: 
  • Somerset Reinsurance Ltd. ("Somerset"), a leading provider of reinsurance solutions to the U.S. life insurance and annuity market, announced today the close of its reinsurance transaction with Prudential Financial, Inc. (NYSE: PRU) (“Prudential”).
  • The transaction includes $12.5 billion of reserves backing Prudential’s guaranteed universal life policies issued by Pruco Life Insurance Company and Pruco Life Insurance Company of New Jersey.
  • Wells Fargo Securities, LLC served as exclusive financial advisor and Willkie Farr & Gallagher LLP served as legal counsel to Prudential for the transaction.
  • RBC Capital Markets served as financial advisor and Mayer Brown LLP served as legal counsel to Somerset Re for the transaction.